Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-29
2005-03-29
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S008100, C530S350000
Reexamination Certificate
active
06872703
ABSTRACT:
A protein or a variant thereof, which has a binding activity to IRR and the following characteristics and an insulin receptor-related receptor are allowed to bind in the presence of a test substance, and inhibition of the binding is measured to search for an agonist or antagonist of IRR ligand.(a) it has the amino acid sequence of SEQ ID NO: 1;(b) it has a molecular weight measured by mass spectrometry using the Fourier transformation ion cyclotron method of about 6135, 6206, 6250 or 6321.
REFERENCES:
patent: WO 9115510 (1991-10-01), None
patent: WO 9315195 (1993-08-01), None
patent: WO 9852607 (1998-11-01), None
P. Shier, et al., The Journal of Biological Chemistry, vol. 264, No. 25 pps. 14605-14608, “Primary Structure of a Putative Receptor for a Ligand of the Insulin Family,” Sep. 5, 1989.
I. Hirayama, et al., Diabetes, vol. 48, pps. 1237-1244, “Insulin Recetptor-Related Receptor is Expressed in Pancreatic β-Cells and Stimulates Tyrosine Phosphorylation of Insulin Receptor Substrate-1 and -2,” Jun. 1999.
R. R. Reinhardt, et al., Endocrinology, vol. 133, No. 1, pps. 3-10, “Insulin Receptor-Related Receptor Messenger Ribonucleic Acid is Focally Expressed in Sympathetic and Sensory Neurons and Renal Distal Tubule Cells,” 1993.
V. M. Watt, et al., Adv. Exp. Med. Biol., vol. 343, pps. 125-132, “IRR: A Novel Member of the Insulin Receptor Family,” 1994.
A. Bateman, et al., Biochemical and Biophysical Research Communications, vol. 173, No. 3, pps. 1161-1168, “Granulins, a Novel Class or Peptide Form Leuckocytes,” Dec. 31, 1990.
M. Shoyab, et al., Proc. Natl. Acad. Sci. USA, vol. 87, pps. 7912-7916, “Epithelins 1 and 2: Isolation and Characterization of Two Cysteine-Rich Growth-Modulating Proteins,” Oct. 1990.
J. Zhou, et al., The Journal of Biological Chemistry, vol. 268, No. 15, pps. 10863-10869, “Purification of an Autocrine Growth Factor Homologous with Mouse Epithelin Precursor from a Highly Tumorligenic Cell Line,” May 25, 1993.
S-Q. Xu, et al., The Journal of Biological Chemistry, vol. 273, No. 32, pps. 20078-20083, “The Granulin/Epithelin Precursor Abrogates the Requirement for the Insulin-Like Growth Factor 1 Receptor for Growth in Vitro,”Aug. 7, 1998.
J-M. Culouscou, et al., The Journal of Biological Chemistry, vol. 268, No. 14, pps. 10458-10462, “Biochemical Analysis of the Epithelin Receptor,” May 15, 1993.
X. Xia, et al., Biochemical and Biophysical Research Communications, vol. 245, No. 2, pps. 539-543, “Identification of Cell Surface Binding Sites for PC-Cell-Derived Growth Factor, PCDGF, (Epithelin/Granulin Precursor) on Epithelial Cells and Fibroblasts1,” 1998.
G. D. Plowman, et al., The Journal of Biological Chemistry, vol. 267, No. 18, pps. 13073-13078, “The Epithelin Precursor Encodes Two Proteins with Opposing Activities on Epithelial Cell Growth,” Jun. 25, 1992.
V. Bhandari, et al., Proc. Natl. Acad. Sci., vol. 89, pps. 1715-1719, “Isolation and Sequence of the Granulin Precursor cDNA from Human Bone Marrow Reveals Tandem Cysteine-Rich Granulin Domains,” Mar. 1992.
V. Bhandari, et al., Endocrinology, vol. 133, No. 6, pps. 2682-2689, “The Complementary Deoxyribonucleic Acid Sequence, Tissue Distribution, and Cellular Localization of the Rat Granulin Precursor,” 1993.
L. M. Liau, et al., Cancer Research, vol. 60, pps. 1353-1360, “Identification of a Human Glioma-Associated Growth Factor Gene, Granulin, Using Differential Immuno-Asborption1,” Mar. 1, 2000.
Eto Yuzuru
Izumi Tetsuro
Okano Akira
Ajinomoto Co. Inc.
Mertz Prema
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Insulin receptor-related receptor binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin receptor-related receptor binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin receptor-related receptor binding protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3444377